Guselkumab maintenance treatment improves health-related quality of life in patients with moderately to severely active Ulcerative Colitis: Phase 3 QUASAR maintenance study

被引：0
|
作者：
Bressler, B. [1 ]
Peyrin-Biroulet, L. [2 ,3 ]
Afif, W. [4 ]
Samaan, M. A. [5 ]
Wei, S. C. [6 ]
Yarandi, S. [7 ]
Germinaro, M.
Mistry, P. [8 ]
Han, C. [9 ]
Allegretti, J. R. [10 ]
Lichtenstein, G. R. [11 ]
机构：
[1] Univ British Columbia, Gastroenterol, Vancouver, BC, Canada
[2] Univ Lorraine, Inserm, NGERE, F-54000 Nancy, France
[3] Grp Hosp Prive Ambroise Pare Hartmann Paris IBD Ct, Gastroenterol, Nancy, France
[4] McGill Univ Hlth Care, Div Gastroenterol, Montreal, PQ, Canada
[5] Guys & St Thomas NHS Fdn Trust, Inflammatory Bowel Dis Unit, London, England
[6] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[7] Janssen Res & Dev LLC, Immunol, Spring House, PA USA
[8] Janssen Res & Dev LLC, Biostat, Spring House, PA USA
[9] Janssen Res & Dev LLC, Patient Reported Outcomes, Spring House, PA USA
[10] Harvard Med Sch, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA USA
[11] Univ Penn, Gastroenterol, Philadelphia, PA USA
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1343
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1169
引用
收藏
页码：i2133 / i2135
页数：3
相关论文
共 50 条
  • [41] Upadacitinib improved fatigue and health-related quality of life in patients with moderately to severely active Crohn's disease: Results from induction and maintenance phase 3 trials
    Ghosh, S.
    Feagan, B.
    Parra, R. S.
    Lopes, S.
    Steinlauf, A.
    Kakuta, Y.
    Joshi, N.
    Lee, W. J.
    Remple, V.
    Lacerda, A. P.
    Zhou, Q.
    Xuan, S.
    Louis, E.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 560 - +
  • [42] UPADACITINIB IMPROVED FATIGUE AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM INDUCTION AND MAINTENANCE PHASE 3 TRIALS
    Ghosh, Subrata
    Feagan, Brian G.
    Parra, Rogerio S.
    Lopes, Susana
    Steinlauf, Adam F.
    Kakuta, Yoichi
    Joshi, Namita
    Lee, Wan-Ju
    Remple, Valencia
    Lacerda, Ana P.
    Zhou, Qian
    Xuan, Si
    Louis, Edouard
    GASTROENTEROLOGY, 2023, 164 (06) : S1106 - S1106
  • [43] Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Final Results From the Phase 3 U-ACHIEVE Maintenance Study
    Vermeire, Severine
    Danese, Silvio
    Zhou, Wen
    Yao, Xuan
    Ilo, Dapo
    Liu, John
    Hebuterne, Xavier
    Lindsay, James
    Sanchez-Gonzalez, Yuri
    Higgins, Peter D.
    Colombel, Jean-Frederic
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S521 - S522
  • [44] Health-Related Quality of Life During One Year of MMx® Mesalamine Maintenance Treatment in Patients With Quiescent Ulcerative Colitis
    Hodgkins, Paul
    Yarlas, Aaron
    Yen, Linnette
    Solomon, Dory M.
    Karlstadt, Robyn G.
    Kane, Sunanda V.
    GASTROENTEROLOGY, 2011, 140 (05) : S203 - S203
  • [45] Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis
    Yasuo Suzuki
    Satoshi Motoya
    Hiroyuki Hanai
    Toshifumi Hibi
    Shiro Nakamura
    Andreas Lazar
    Anne Martin Robinson
    Martha Skup
    Nael Mohamed Mostafa
    Bidan Huang
    Roopal Thakkar
    Mamoru Watanabe
    Journal of Gastroenterology, 2017, 52 : 1079 - 1079
  • [46] Improvement in Inflammatory Biomarker Levels Through Week 12 in Moderately to Severely Active Ulcerative Colitis Patients Treated With Guselkumab: Results From the Phase 3 QUASAR Induction Study
    Hisamatsu, Tadakazu
    Peyrin-Biroulet, Laurent
    Dignass, Axel
    Huang, Kuan-Hsiang G.
    Germinaro, Matthew
    Houck, Nicole
    Miao, Ye
    Zhang, Hongyan
    Argollo, Marjorie
    Takeuchi, Ken
    Filip, Rafal
    Allegretti, Jessica R.
    Feagan, Brian G.
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S810 - S810
  • [47] Predictors of health-related quality of life in patients with moderate to severely active ulcerative colitis receiving biological therapy
    Rasmussen, Bjorn
    Haastrup, Peter
    Wehberg, Sonja
    Kjeldsen, Jens
    Waldorff, Frans Boch
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (06) : 656 - 663
  • [48] PRA023 Improved Health-Related Quality of Life as Measured by IBDQ-32 in a Phase 2 Trial in Patients with Moderately to Severely Active Ulcerative Colitis
    Rubin, David T.
    Sands, Bruce E.
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Nguyen, Deanna D.
    Dinh, Quinn
    Dong, Bin
    Ma, Christopher
    Ritter, Timothy E.
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S678 - S678
  • [49] Predictors of health-related quality of life in patients with moderate to severely active ulcerative colitis receiving biological therapy
    Rasmussen, B.
    Haastrup, P.
    Wehberg, S.
    Kjeldsen, J.
    Waldorff, F. Boch
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S506 - S507
  • [50] Relationship Between Health-Related Quality of Life and Work Productivity in Patients With Ulcerative Colitis in the Tofacitinib OCTAVE Phase 3 Induction and Maintenance Studies
    Targownik, Laura
    Dubinsky, Marla C.
    Steinwurz, Flavio
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Tai, Elaine
    Gardiner, Sean
    Hur, Peter
    Panes, Julian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S753 - S754
12345